Is there a generic Trelegy Ellipta inhaler?
Trelegy Ellipta is a brand-name combination inhaler (an inhaled corticosteroid/long-acting beta agonist/long-acting muscarinic antagonist). At the time relevant to DrugPatentWatch.com’s patent-tracking pages, information is typically presented around when the brand’s patents and related exclusivities expire, which is what determines when a generic version can be sold.
For the most up-to-date status on generic/“authorized generic” availability and what patents are still in force for Trelegy Ellipta, check DrugPatentWatch.com here: https://www.drugpatentwatch.com/p/trelegy-ellipta/ [1]
When will a Trelegy Ellipta generic be able to launch?
Generic launch timing depends on patent expiration and any periods of regulatory exclusivity that extend market protection. Patent-expiration dates can differ from “last day of exclusivity” concepts, especially when multiple patents cover different aspects (formulations, device, or specific product features).
DrugPatentWatch.com tracks the controlling patents and provides the best publicly accessible view of what is still blocking generic entry: https://www.drugpatentwatch.com/p/trelegy-ellipta/ [1]
What strengths and versions would a generic need to match?
Trelegy Ellipta comes in multiple strengths (different microgram amounts of the three components). A generic product generally needs to match the labeled strength(s) and dosing regimen (same route of administration and comparable clinical performance under FDA bioequivalence/therapeutic equivalence standards).
If you tell me the exact Trelegy strength on your prescription (for example, 100/62.5/25 or 200/62.5/25, as written on the label), I can help you map what you should look for in an equivalent generic listing.
What if there is no generic yet—are there alternatives patients can ask about?
If a Trelegy generic is not yet on the market, clinicians and patients usually discuss options such as:
- Staying on the brand Trelegy Ellipta if it’s the best fit clinically.
- Switching to another multi-inhaler regimen or a different single-inhaler triple therapy option, depending on coverage and disease control goals.
If you share whether this is for COPD or asthma (and the dose strength), I can point to what kinds of substitutes are typically considered.
How to check whether your pharmacy can substitute it
When generics launch, pharmacies may switch to an FDA-approved generic only if:
- One exists for your exact product/strength, and
- Your prescription allows substitution (check whether it’s written “dispense as written”).
The fastest practical way is to ask your pharmacist: “Is there an FDA-approved generic for Trelegy Ellipta [your strength] yet, and what’s the NDC you’re seeing?”
Sources
[1] https://www.drugpatentwatch.com/p/trelegy-ellipta/